A B S T R A C T Bolus injections of gastrin or pentagastrin (PG) cause a marked elevation in lower esophageal sphincter pressure (LESP), and it has been suggested that serum gastrin concentration is the main physiological and pathophysiological regulator of LESP. We evaluated this hypothesis by measuring LESP and gastric acid secretion simultaneously in normal subjects during continuous infusion of PG (0.004-12 /Lg/ kg per h), since continuous infusion of a hormone probably simulates physiological hormone release better than bolus injection. In groups of 8-13 subjects there was no statistically significant increase in average LESP with any of seven PG infusion rates. However, a bolus of PG superimposed on the continuous infusion of PG resulted in a 20-mm Hg increase in LESP. Examination of results in individual subjects suggested that PG by infusion might be stimulating LESP in some subjects and inhibiting it in others. Therefore, individual dose-response studies were performed in two normal subjects. These revealed that 0.9 /Ag/kg per h PG by infusion elevated LESP by 10-12 mm Hg. This dose of PG also elicited maximal rates of gastric acid secretion. In one of the subjects an infusion of PG calculated to give one-half maximal acid secretion (Dw) elevated LESP by 8 mm Hg; in the other the PG-D6o for acid secretion had no effect on sphincter pressure. Infusion of smaller amounts of PG had no effect on LESP, even though gastric acid secretion was stimulated submaximally.
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Preliminary results of this study were reported in abstract form in Gastroenterology. 1973 (2, 8) , and deacidification of the stomach (6, 8 (2-4, 6, 8) , ingestion of a protein meal that has been previously acidified to pH 1.5 (7) , and intravenous injection of gastrin antiserum (5) .
On the basis of these results it has been concluded that gastrin plays the major role in maintenance of resting LESP (3, 5, 9) and in increasing LESP under conditions where gastroesophageal reflux might otherwise occur (1, 2, 7). Furthermore, hypersensitivity to endogenous gastrin has been proposed as the cause of increased sphincter pressure in achalasia (4), and defective endogenous release has been proposed as the cause of sphincter incompetence in patients with reflux esophagitis (6) . It has also been suggested that changes in sphincter pressure may be utilized to monitor endogenous gastrin activity (7) and that LESP is a more precise measure of circulating gastrin than radioimmunoassay (10) .
In previous studies on the effect of gastrin or PG on LESP the hormones have been given almost exclusively by intravenous injection as a bolus or by subcutaneous administration. If gastrin is an important physiological stimulant of LESP, one would expect that continuous infusion of gastrin or PG would also increase LESP. However, the effect of continuous infusion of PG or gastrin on LESP has not been previously studied in detail. We have therefore measured the effect of a continuous 1-h infusion of PG on LESP and correlated this with the acid secretory response by the parietal cells of the stomach. We sought answers to two main questions. First, does the lower esophageal sphincter (LES) contract in response to a continuous infusion of PG, and if so, is the contraction transient, as it is after a bolus of PG, or does it last throughout the length of the infusion? And second, assuming that the sphincter contracts to a continuous infusion of PG, what is the relative sensitivity of the LES muscle and the gastric parietal cells to PG infusion? These studies were performed in normal human subjects using a wide range of PG infusion rates, from a dose so low that it did not increase gastric acid secretion to a dose that is higher than that required to elicit maximal acid secretion rate. In addition, we determined the correlation between unstimulated LESP and gastric acid secretion (i.e., with saline rather than PG infusion).
METHODS
Subjects. Studies were done on normal men and women who did not have any known disorder of the gastrointestinal tract. None of the subj ects had any clinical symptoms of esophageal reflux. All subjects were studied after an overnight fast and in the supine position. No drugs of any kind were given for 12 h before the study. None of the subjects were taking anticholinergic drugs, tranquilizers, or barbiturates. Manometric recording system. Respiration and swallowing were monitored by a belt pneumograph. A single waterfilled polyvinyl tube was used for measuring LESP. This tube had an internal diameter of 1.7 mm and a lateral orifice that was 1.5 mm in diameter. The tube was perfused with saline at a rate of 0.76 ml/min by means of a Harvard infusion pump (Harvard Apparatus Co., Inc., Millis, Mass.). A Statham transducer (model P23Db, Statham Instruments, Inc., Oxnard, Calif.), and either a recorder (Electronics for Medicine Inc., White Plains, N. Y.) or a Physiograph (Narco Bio-Systems, Inc., Houston, Tex.) were used for pressure measurements.
The pressure recording tube was mounted with tetrahydrofuran to a 16-Fr polyvinyl sump tube (Anderson Products, Inc., Oyster Bay, N. Y.) that was, in turn, used for removing gastric secretions. The opening of the pressure recording tube was 15 cm from the end of the sump tube. The combined outside measurement of the two-tube assembly was 4.5 X 6.5 mm.
Gastric secretion. Gastric contents were removed by suction to the sump tube, which was positioned fluoroscopically in the antrum of the stomach. Hydrogen ion concentration was measured by the method of Moore and Scarlata (11) .
Experimental protocol. The study was divided into three parts. First, isotonic saline was infused intravenously for a control period of 30 min. During the second period, PG2 was infused intravenously for 1 h. The third period was begun by replacing the PG infusion with saline, which was infused for a final 40-min period.
The effects of different doses of PG were measured in different groups of 8-13 subjects (designated the "group dose-response studies"), and 2 subjects had a complete dose-response examination (four or five studies at each of seven doses, designated the "individual dose-response studies"). In the group dose-response studies, the protocol was modified with the 0.9 and 1.5 ,g/kg per h PG infusions in that 0.5 jig/kg PG was injected intravenously as a bolus at the end of the 1-h PG infusion. This is known to elicit a maximal LES contraction in otherwise unstimulated subjects (6, 12) . The bolus was injected while the intravenous infusion of PG was still running.
Using mean gastric fundal pressure as a zero reference, LES pressure was measured at 15-min intervals during the first and third periods and at 10-min intervals during the second (PG) period. At each interval LESP was measured by two pull-throughs of the entire length of the LES. The highest pressure recorded at the end of inspiration was taken as the LESP for each pull-through, and the results of the two pull-throughs (done within a 4-min period) were averaged. Fig. 1 shows the correlation of the first with the second pull-through when saline was infused throughout the three periods of study (placebo infusion in 13 subjects). While the two results often differed, overall there was good reproducibility, with a correlation coefficient of 0.87. Thus, the average of two pull-through pressures taken at 10-and 15-min intervals should be adequate to detect relative changes in LESP induced by continuous infusion of PG.
In contrast to the pull-through method, the response of the sphincter to the bolus doses of PG was measured with the aperture of the catheter anchored in the LES.
RESULTS
Group dose-response studies. Fig. 3 , an intravenous bolus injection of PG (0.5 iig/kg) superimposed on the 0.9 and 1.5 jg/kg per h PG infusion caused LESP to increase by approximately 20 mm Hg (P < 0.001).
Although PG by infusion failed to increase average LESP, examination of the results in individual subjects sometimes suggested that a given dose of PG might stimulate or inhibit LESP. Two examples are shown in Fig. 4 . However, LESP sometimes changed during the course of a saline control infusion (Fig. 5) , making it hazardous to interpret the results of a single study.
Individual dose-response studies. Additional studies were carried out in two normal subjects who agreed to have four measurements of LESP at PG infusion rates of 0.01, 0.025, 0.05, 0.1, 0.9, and 2.1 pg/kg per h. LESP in subject A. C. (Fig. 6 ) was increased from 37 to a peak of 50 mm Hg with the 0.9 ag/kg per h infusion rate (P < 0.05). Other doses of PG had no statistically significant effect. LESP in subject G. H. ( (Fig. 8, right side) .
Correlation of acid secretion and LESP. During the control saline infusion in subjects A. C. and G. H. (Figs. 6-8 with a 20-mm rise in pressure, indicating tha still sensitive to the effects of a bolus injection Although these average results with continu infusions were negative insofar as splincter traction was concerned, an examination of th( in individual subjects made us hesitant to concl PG by constant infusion has no stimulatory e LESP. Specifically, some subjects apparently d4 a modest increase in LESP after PG infusion, b were canceled by other subjects in whom PG to depress LESP. However, speculation based o studies was hazardous since sphincter pressui changed in subjects infused with the saline cont Two subjects were therefore selected at rat have four or five tests performed at each of se infusion rates. In both subjects the infusion of kg per h PG elevated LESP by about 12 mm ALINE dose of PG also resulted in maximal stimulation of acid secretion. Both subjects were studied at a dose of PG calculated to give one-half maximal rate of acid secretion; 5 in one this PG infusion rate caused the LESP to rise by 8 mm Hg, whereas in the other LESP was not effected. In neither subject did smaller doses of PG elevate LESP, even though acid secretion was increased. Thus, the parietal cells are more sensitive than the LES to the effects of PG infusion. In one of the sub-
jects a dose of PG larger than that required for maximal acid secretion inhibited LESP transiently. When LESP did increase with PG infusion, the on--,---,-set of the rise was variable, sometimes occurring within 130 the first 10 min of starting the infusion and sometimes not occurring until 30 or 40 min after the PG infusion was started. Once increased, LESP tended to remain elevated for the duration of the PG infusion. When PG ALINE was stopped, LESP returned to the base line within 15 min., even though gastric acid secretion remained much higher than the control value for at least 30 min afterwards.
We conclude from these individual dose-response studies that the LES response to PG by infusion is biphasic. First, within a narrow dose range PG by infusion causes the LES to contract. Second, at higher PG infusion rates the LESP is no longer increased, and at least in some subjects it is transiently inhibited. Most likely, the dose that will elicit a contraction or *-* relaxation of the LES varies in different subjects, and this is probably the reason why average results in dif--r--ferent groups of subjects failed to reveal any evidence 130 of sphincteric contraction in response to continuous infusion of a wide range of doses; i.e., a given dose of kg per h PG might cause contraction in some subjects and relaxr elevated ation in others, so that average sphincter pressure reduced would not change.
The rise in LESP after continuous infusion of PG was much less than expected on the basis of studies in t it was uof PG. which PG has been injected intravenously as a bolus. For example, most workers report an LESP rise of about 40 mm Hg after a bolus of 0.5 pg/kg PG (5, 6, 12) , whereas the highest increase in pressure we could document after PG infusion was about 12 mm Hg. However, even our highest PG infusion rates probably do not result in steady blood or tissue concentration of PG comparable to those reached transiently after a bolus injection of 0.5 ig/kg PG. The reason why bolus injections of PG elicit a stronger contraction of the LES than is attained by constant PG infusion might therefore be because tissue concentrations are higher with the bolus. Alternatively, or in addition, continuous infusion of PG may cause the sphincter to become partially refractory to the stimulatory effect of PG (13, 14) .
Because of the suggestion that basal LESP is determined by serum gastrin concentration (3, 5, 9) and that LESP gives an accurate assessment of serum gastrin activity (7, 10) , it was of interest to correlate basal LESP and basal acid secretion in our two subjects who were studied repeatedly. The basal LESP in these subjects was highly variable from day to day (from 16 to 71 mm Hg), but on a given day LESP was relatively stable. If this variation in day to day LESP was caused by different serum gastrin concentrations, gastric acid secretion should be high when the LESP in high, assuming that parietal cells are more sensitive than the LES to gastrin, as they are to PG. Basal LESP and gastric acid secretion were measured simultaneously on 29 separate test days in these two subjects, and there was no correlation between these two activities. This suggests that the wide day-to-day fluctuation in LESP is not due to changing concentration of gastrin in serum. Whether or not the fluctuations in basal acid secretion (from 0 to 6 meq/h) were due to differences in serum gastrin concentration is not known; however, this does not detract from our conclusion that changing LESP is not due to differences in serum gastrin concentration, provided our assumption is correct that parietal cells are more sensitive than LES muscle to changes in the concentration of serum gastrin(s) as they are to PG.
The present experiments confirm the previously known fact (15) that LESP is quite variable from day to day in the same normal subject, but they cast doubt on the hypothesis that serum gastrin concentration is the main determinant of LESP. Most likely there are multiple controls. Our data suggest that serum gastrin concentration could be one of these. For example, a rise in serum gastrin concentration might be the cause of the 4-8 mm Hg rise in LESP that is said to occur from 10 to 60 min after subjects ingest a high protein meal (7) , provided the serum gastrin response to the meal was within the relatively narrow range required to stimulate contraction of the sphincter. It is very unlikely, however, that physiological changes in gastrin concentration could be responsible for the wide range of LESP that occur when a normal person is studied on different days (from 16 to 71 mm Hg in our two subjects) ; judging from our results, physiological changes in gastrin concentration could never cause more than an 8-12 mm Hg change in LESP. Therefore, we conclude that the role of gastrin as a physiological regulator of LESP is relatively minor.
